Steve Hamburg 
The Courage to Say No
We, as pharma marketers today, are surrounded by more. We have more clinical trial ...
Vical Announces News Release and Conference Call Schedule for Third Quarter 2017 Financial Results
SAN DIEGO, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that ...
AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors
NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...
Global Ginger Market to touch US$4.18 Billion by 2022 – Transparency Market Research
ALBANY, New York, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Characterized by the presence of ...
FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares
FIT Biotech Oy Company release October 16, 2017 at 10:00 AM EET Conversion of ...
BioAegis Therapeutics Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase 2 Clinical Trials in Community-Acquired Pneumonia
BOSTON and MORRISTOWN, N.J., Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a ...
Trinity Biotech plc to Announce 2017 Third Quarter Financial Results
DUBLIN, Ireland, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading ...
Antiviral Therapeutics Companies, Technologies and Markets, 2026
Dublin, Oct. 12, 2017 (GLOBE NEWSWIRE) -- The "Antiviral Therapeutics - Technologies, Markets and ...
